Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11891439 Antibodies and assays for CCL14

Patent 11891439 was granted and assigned to Astute Medical on February, 2024 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Astute Medical

Current Assignee

Astute Medical

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

118914390

Patent Inventor Names

Ravi A Vijayendran0

Hua Wang0

Date of Patent

February 6, 2024

Patent Application Number

169580720

Date Filed

December 28, 2018

Patent Citations

‌

US Patent 7214775 Method of modulating the activity of functional immune molecules

‌

US Patent 6946292 Cells producing antibody compositions with increased antibody dependent cytotoxic activity

‌

US Patent 7125493 Highly asymmetric, hydrophilic, microfiltration membranes having large pore diameters

‌

US Patent 7657380 Methods of generating variant antibodies with increased host string content

Patent Primary Examiner

‌

Nora M Rooney

Patent abstract

The invention provides CCL14 antibodies.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11891439 Antibodies and assays for CCL14

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API